GlassScriptPhysician profile
Thomas Adekunle Owolabi
NPI 1649732983
$13,719.52
in general payments reported to CMS, 2019-2025
27 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,235 · 2023: $4,494 · 2024: $2,854 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,859 · Travel and Lodging: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,859.11 |
| Travel and Lodging | $1,625.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,833.43 | 2022-2025 | Hoffmann, Salvation, Augment Injectable |
| Paragon 28, INC. | $1,133.92 | 2022-2023 | Activcore Nail |
| Smith+Nephew, INC. | $936.14 | 2022-2025 | Grafix Pl, Collagenase Santyl, Grafix |
| Orthofix Medical, INC. | $756.10 | 2022 | |
| Biotissue Holdings INC. | $242.46 | 2022 | |
| Depuy Synthes Sales INC. | $184.67 | 2025 | Motoband |
| Mimedx Group, INC. | $161.73 | 2024 | |
| Medinc of Texas | $156.52 | 2022-2025 | |
| Amgen INC. | $149.45 | 2025 | Krystexxa |
| Abbvie INC. | $125.00 | 2024 | |
| Paratek Pharmaceuticals, INC. | $121.74 | 2023-2025 | Nuzyra |
| Trimed, INC. | $121.46 | 2022 | |
| Restor3d, INC. | $116.48 | 2023 | |
| Polynovo North America LLC | $106.16 | 2024-2025 | Novosorb Btm |
| Treace Medical Concepts, INC. | $92.67 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $67.80 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $63.20 | 2024-2025 | Restrata Wound Matrix |
| Convatec INC. | $53.95 | 2025 | |
| Alafair Biosciences, INC. | $47.88 | 2023-2025 | Versawrap |
| Bioventus LLC | $45.08 | 2022-2025 | Durolane |
| Arthrosurface Incorporated | $43.37 | 2025 | Toe Motiontm |
| Horizon Therapeutics Plc | $39.82 | 2023 | Krystexxa |
| Curonix LLC | $34.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $28.74 | 2022 | |
| Aroa Biosurgery Incorporated | $22.04 | 2023 | |
| Nevro Corp. | $21.56 | 2024 | Senza |
| Organogenesis INC. | $14.00 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Owolabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.